Learn more

SHANGHAI CLAISON BIOTECHNOLOGY CO LTD

Overview
  • Total Patents
    19
  • GoodIP Patent Rank
    222,960
About

SHANGHAI CLAISON BIOTECHNOLOGY CO LTD has a total of 19 patent applications. Its first patent ever was published in 2011. It filed its patents most often in China. Its main competitors in its focus markets biotechnology are ANTHONY NOLAN BONE MARROW TRUS, JM DNA SHANGHAI BIOLOG MEDICAL TECHNOLOGY CO LTD and SUREXAM BIOLOG TECHNOLOGY CO LTD.

Patent filings in countries

World map showing SHANGHAI CLAISON BIOTECHNOLOGY CO LTDs patent filings in countries
# Country Total Patents
#1 China 19

Patent filings per year

Chart showing SHANGHAI CLAISON BIOTECHNOLOGY CO LTDs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Biotechnology

Focus technologies

Top inventors

# Name Total Patents
#1 Ye Yongqing 15
#2 Su Guoxin 15
#3 Zhang Chao 4
#4 Lu Lingling 4
#5 Zhang Zan 3
#6 Tang Tianjuan 2
#7 Qian Ni 2
#8 Xie Shangyun 2
#9 Tan Lingbing 2
#10 Zhang Yan 2

Latest patents

Publication Filing date Title
CN106520922A Mycoplasma detection kit and method for cultivating immune cells
CN105176926A Method for amplifying NK cells through in-vitro cultivation
CN104001185A Preparation method of specific dendritic cell vaccine of CEA positive tumor
CN102993313A GM-CSF-TAT-CEA recombinant protein, method and application thereof
CN102993292A AFP (Alpha Fetal Protein) recombinant protein and in-intro recombinant expression method
CN102994552A Method for expressing TAT-apoptin fusion proteins by Bac-to-Bac system
CN102993312A GM-CSF-HER2 recombinant protein, method and application thereof
CN102994448A Method for in-vitro amplification of gamma-delta-T cells
CN102978160A Method for inducing and amplifying natural killer T (NKT) cells in vitro
CN102994449A Method for in-vitro amplification of NK cells
CN102352342A Method for amplifying cytokine induced kill cells (CIK) and CIK cell preparation
CN102352343A Lymphocyte culture medium and use method thereof